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Abstract  
Context: There is an unmet clinical need to develop simple, easy, rapid, and accessible testing for the detection 
of SARS-CoV-2. Recent reports suggested that saliva may be a host for the virus. The existence of SARS-CoV-2 
in saliva can be associated with oral manifestations in infected patients. A systematic review was conducted as 
well as a meta-analysis to evaluate the diagnostic accuracy of detecting SARS-CoV-2 in saliva and investigate 
the association between positive saliva test and oral manifestations of COVID-19.  
Evidence acquisition: A literature search in MEDLINE via PubMed, Scopus, Web of Science, and Cochrane was 
done in June 2020 and updated in February 2021 using relevant keywords. We screened studies for eligibility. 
The extracted data were analyzed using Meta-Disc software.  
Results: Eighteen studies were included. Pooled data from eligible studies showed that the sensitivity of 
diagnosis of SARS-CoV-2 in saliva was 0.86 (95% CI, 0.83–0.89), and the specificity was 0.98 (95% CI, 0.96–
0.98). COVID-19 was associated with oral diseases as amblygeustia, dry mouth, dryness, inflammation of the 
mouth, and enlargement of lymph nodes in the submandibular regions. 
Conclusions: Our results showed that the saliva has a high accuracy in the detection of SARS-CoV-2. 
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CONTEXT  
Since the outbreak of COVID-19, the configuration 
of the clinical picture and mode of transmission has 
become a global requirement. The initial diagnosis 
of COVID-19 is routinely made by a nasopharyngeal 
swab and Real-Time Reverse Transcription 
Polymerase Chain Reaction (RT-PCR) of the 
respiratory specimen (1, 2).  
The nasopharyngeal swab has many drawbacks, 
for it is a sensitive and bothersome technique for 
the patient. Other drawbacks include coughing, 
sneezing, or even gaging, which puts the medical 
staff at a higher risk of infection, another reason 
why there has been an increasing demand to 
develop new methods for COVID-19 screening and 
diagnosis (3, 4).  
Detection of the virus in saliva could present a 
lower risk rate and straightforward procedure for 
diagnosis (5). The presence of severe acute 
respiratory syndrome coronavirus 2 (SARS-COV-2) 
in the oral cavity could be due to many reasons: 
through droplets from the respiratory tract, 
through blood, or from the salivary gland (6). 
Angiotensin-converting enzyme 2 (ACE2) 
receptors, the main target receptor of COVID-19, 
are widely present in lungs and also the salivary 
glands (7). And it is reported that the virus can be 
detected in the saliva up to one month after the 
infection (8).  
This review aimed to evaluate the diagnostic 
accuracy of detecting SARS-CoV-2 in saliva rather 
than nasopharyngeal specimen, and further, 
investigate the possible association between 




We searched the following databases: MEDLINE via 
PubMed, Scopus, Web of Science, and Cochrane 
Central Register until the date of June 2020, and 
updated in February 2021. The following search 
strategy has been used: (“2019 novel coronavirus 
disease” OR covid19 OR “COVID-19 pandemic” OR 
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“SARS-CoV-2 infection” OR “COVID-19 virus 
disease” OR “2019-nCoV infection” OR 
“coronavirus disease 2019” OR “coronavirus 
disease-19” OR “2019-nCoV disease” OR “COVID-
19 virus infection” OR “Wuhan coronavirus” OR 
“Wuhan seafood market pneumonia virus”) AND 
(Saliva OR “nasopharyngeal swab” OR “or 
pharyngeal swab”).  
Eligibility criteria and study selection 
We included all relevant articles about the 
detection of SARS-COV-2 without restriction on age 
or medical conditions. Studies evaluated the 
accuracy of virus detection by RT-PCR in the saliva 
compared to the standard diagnosis of SARS-CoV-2 
by RT-PCR in nasopharyngeal swabs.  
We excluded animal, conference, non-English 
studies, reviews, and studies with unreliable data 
for extraction. Screening for eligibility was 
performed in two steps: firstly, abstracts were 
screened. Secondly, full-text articles of eligible 
abstracts were retrieved to meta-analysis. 
Data Extraction 
We extracted the following data from the included 
studies using a formatted data extraction sheet for 
summary and baseline of the included studies, 
including study ID, country, sample size, age, 
sample source, and the number of patients who 
were positive by detection of the virus in saliva. 
Quality assessment 
The quality of included studies was performed by 
two authors using the “QUADAS-2: a revised tool 
for the quality assessment of diagnostic accuracy 
studies”. QUADAS-2 tool is applied in 4 phases: 
summarize the review question, tailor the tool and 
produce review-specific guidance, construct a flow 
diagram for the primary study, and judge bias and 
applicability (9). 
Statistical analysis 
We analyzed the data using Meta-Disc (version 
1.4), and a P-value <0 .05 was considered 
statistically significant. Heterogeneous data was 
analyzed by random model. We calculated the 
sensitivity, specificity, positive likelihood ratio 
(PLR), negative likelihood ratio (NLR), diagnostic 
odds ratio (dOR), the summary receiver operating 
characteristic (sROC) curve, and the area under the 
ROC, and corresponding 95% confidence intervals 
(CIs) from true positive, false positive, false 
negative, and true negative cases. A random effects 
model was applied to summarize the sensitivity, 
specificity, PLR, and NLR. 
RESULTS 
Literature search 
The primary literature search retrieved 2683 
citations, and after the removal of duplication, 
2210 studies were eligible for screening. Following 
title and abstract screening, 61 articles were 
retrieved for full-text evaluation. Eighteen studies 
that match our criteria were included in the meta-
analysis (See PRISMA flow diagram; Figure 1).  
Characteristics and quality of included studies 
The summary and baseline characteristics of 
enrolled patients are shown in appendix 1. 
According to QUADAS-2 Quality Assessment tool, 
the quality assessment of the included studies 
ranged from moderate to high quality as showed in 
figure 2; the summary of quality assessment of each 
study is shown in table 1.  
Qualitative evidence  
Chen 2020 et al. (10) reported that SARS-CoV-19 
was positively detected in the saliva of 4/13 cases; 
three of them were critically ill while one was an 
ordinary patient. This result confirmed the 
possibility of 2019-nCoV being present in saliva. It 
was also reported that oral-associated symptoms 
might be related to COVID-19, including 
amblygeustia (47.2%), dry mouth (46.3%), 
dryness, and inflammation of mouth (11.1%), and 
enlargement of lymph nodes in the submandibular 
regions (0.9%). Azzi 2020a et al. (5) reported that 
saliva is a reliable biological fluid that could be a 
candidate for SARS-COV-2, the virus may appear in 
mouth during migration from nasopharynx or the 
lower respiratory tract. Caly 2020 et al. (11) 
reported a case report of a 58-year-old man from 
Wuhan, who showed that SARS-COV-2 significantly 
detected in nasopharyngeal swab and sputum on 
RT-PCR. The viral load daily testing showed a 
gradual decline in sputum after eight days of 
 
Figure 1: PRISMA flow diagram 
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admission. They reported that the virus was not 
detected in urine, plasma, and fecal samples. Azzi 
2020b et al. (12) reported that the salivary sample 
collected from the 64-year-old man was positive 
after the first and second swabs after two days, 
while the two bronchoalveolar swabs were 
negative. To 2020b et al. (23), Zheng 2020 et al. 
(24), and Cheng 2020 et al. (25) recommended the 
saliva as a noninvasive procedure, also it 
associated with reducing nosocomial transmission 
of SARS-CoV-2.  
Quantitative evidence on the accuracy of SARS-
CoV-2 detection in the saliva 
The overall diagnostic measurements for detecting 
SARS-Cov-2 in saliva specimen was summarized in 
figure 3. The pooled sensitivity was 0.86 (95% CI, 
0.83–0.89), and the pooled estimation showed 
significant heterogeneity (p=0.001, chi-square 
= 37.69, I2 = 73.5%) (Figure 3A). Meanwhile, the 
summary specificity was 0.98 (95% CI, 0.96–0.98), 
and the pooled estimation also showed noticeable 
heterogeneity (p= 0.001, chi-square = 292.24.40, 
I2 = 96.6%) (Figure 3B). The pooled dOR was 
194.12 (95% CI, 37.06–1016.7), with significant 
heterogeneity (p=0.001, chi-square= 131, 
I2 = 92.4%) (Figure 3C). The pooled AUC value was 
0.95 ± 0.021 (Figure 3D). All extracted data are 
reported in table 2.  
 
Figure 2: The quality assessment of the included studies 
Table 1: Quality assessment by QUADAS-II checklist 
Study ID 















Caulley 2020(13) High Low Unclear Low Low Low Unclear 
Hanson 2020(14) Unclear Low Low Low Low Low Low 
Iwasaki 2020(15) Unclear Low Low High Low Low Low 
Kojima 2020(16) High Low Low Unclear Low Low Low 
Landry 2020(17) Unclear Unclear Unclear Low Unclear Unclear Unclear 
McCormick-Baw 2021(18) Unclear Low Low Unclear Unclear Low Low 
Pasomsub 2020(19) Unclear Low Low Low Unclear Low Low 
To 2020a(3) Unclear low low low low Unclear Low 
Vaz 2020(20) Unclear Low Low Low Low Low Low 
Williams 2020(21) Unclear Unclear Low Low Low Low Low 
Wong 2020(22) Unclear Low Low Unclear Unclear Low Low 
Chen 2020(10) Unclear Unclear Low Unclear Low Low Low 
To 2020b(23) Unclear Low Low Unclear Unclear Unclear Low 
Azzi 2020a(5) Unclear Low Low Low Low Low Low 
Azzi 2020b(12) Unclear Unclear Unclear low Unclear Unclear Unclear 
Caly 2020(11) Unclear Unclear Unclear low Unclear Unclear Unclear 
Zheng 2020(24) Unclear low low low low Unclear Low 
Cheng 220(25) Unclear Unclear Low Unclear Unclear Low Low 
 
Table 2: SARS-COV-2 Diagnostic indices based on Saliva detection. 
Parameter 
Test of association Test of heterogeneity 
Model 
Estimate 95% CI chi-squared P-value I-square (%) 
Sensitivity 0.86 0.83 - 0.89 37.69 <0.001 73.5 Random 
Specificity 0.98 0.96 - 0.98 292.24 <0.001 96.6 Random 
PLR 29.56 3.33 - 262.27 845.13 <0.001 98.8 Random 
NLR 0.15 0.08 - 0.29 58.41 <0.001 82.9 Random 
dOR 194.12 37.06 - 1016.7 131 <0.001 92.4 Random 
CI = Confidence interval, NLR = negative- likelihood ratio, PLR = positive-likelihood ratio, and dOR = diagnostic odds ratio 
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DISCUSSION 
Summary of finding 
This study provides evidence that SARS-CoV-2 
detection in the saliva gives an 86% sensitivity, and 
98% specificity compared to nasopharyngeal 
specimen which is the gold standard of COVID-19 
diagnosis. The included studies reported the 
reliability of saliva to detect the virus through the 
percentage of true positive patients in all truly 
infected patients.  
Explanation of the study findings 
Saliva is a potential source of the transmission of 
SARS‐CoV-2 (26). Human saliva is a fluid produced 
by salivary glands, contains many components as 
proline‐rich proteins, mucins MG1 and MG2, and 
gp340 (27). These components can interact with 
different pathogens, causing changes in their 
biological behavior (28). We can detect more than 
700 microbial specie in saliva, these 
microorganisms are related to oral and systemic 
diseases, saliva has a role in the colonization of oral 
microorganisms; it also prevents the overgrowth of 
these microorganisms (29). 
Diagnosis of SARS-CoV-2 can be performed with 
the usage of saliva through a nasopharyngeal, 
oropharyngeal swab, or blood samples (30). 
Salivary diagnosis has many advantages as it can be 
extracted easily without invasive processes; also, it 
has a low risk of nosocomial 2019-nCoV 
transmission to healthcare workers (23). It has 
prolonged detection time which is 20 days or more. 
Transmission of SARS-CoV-2 from human-to-
human occurs directly by cough, or sneeze of 
droplets, or indirect contact transmission as saliva, 
or mucous membranes of the nose (31). SARS-CoV-
2 reaches saliva through three routes: infection of 
salivary gland with virus release through salivary 
ducts, virus in the upper and lower respiratory 
tract that reaches the oral cavity through droplets, 
and virus in blood that can reach saliva through the 
gingival crevicular fluid (32).  
Previous studies 
Previous studies demonstrate that saliva has a high 
viral load, especially in posterior oropharyngeal 
saliva samples (33). A recent study indicates that 
SARS-CoV-2 can be easily detected in either in 
bronchoalveolar lavage fluid (93%), sputum 
(72%), nasal swabs (63%), fibro bronchoscope 
brush biopsy (46%), pharyngeal swabs (32%), 
faeces (29%), or blood (1%). No one can however 
detect it in urine specimens (34). A previous 
diagnostic meta-analysis that included non-peer 
reviewed paper reported converging results 83.2% 
for sensitivity and 99.2% for specificity (35). 
Chen 2020 et al. reported an association between 
oral manifestation and COVID-19 as amblygeustia, 
dry mouth, dryness and inflammation of the mouth, 
and enlargement of lymph nodes in the 
submandibular regions (10). The previous study 
  
  
Figure 3: diagnostic measurements meta-analysis for detecting SARS-Cov-2 in Saliva Specimen. (A) Sensitivity, (B) Specificity, (C) 
Diagnostic odds ratio (D) sROC curve 
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reported an association between COVID-19 and 
oral manifestation, including oral pain, gingivitis, 
ulcers, and blisters (36). 
Dentists should take caution while treating 
patients during the pandemic when using mouth 
rinse, and local nasal products that include beta-
cyclodextrins in conjunction with flavonoid agents 
and provide an adjuvant cate to reduce SARS-CoV-
2 transmission (37). 
Strength points & Limitations  
The main strengths of our study are that we 
included only peer reviewed studies while our 
search study and methodology was sensitive. The 
quality of the studies made was high to moderate 
and included quantities evidence. However, we 
have some limitations; a relatively small sample of 
included studies and patients; a heterogenetic of 
results; we included only observational studies, 
which in general, have a high risk of bias and low 
quality of evidence.  
CONCLUSIONS 
In summary, salivary detection of SARS-CoV-2 is 
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This study concluded that ACE2 expressed 
in the salivary gland, and SARS-COV-2 can 
be detected in saliva; also, oral symptoms 
may be frequently manifested by COVID-
19 patients. These findings suggest that 























This study reported that Posterior 
oropharyngeal saliva samples are a non-
invasive specimen more acceptable to 
patients and healthcare workers. This 
finding emphasizes the importance of 
stringent infection control and early use of 
potent antiviral agents, alone or in 
combination, for high-risk individuals. The 
serological assay can complement RT-
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Saliva samples were 






Self-collected saliva samples are an easy, 
convenient, and low-cost alternative to 










flocked swab, throat 





Appropriate hospital infection control 
measures were able to prevent nosocomial 
transmission of SARS-CoV-2. 
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The study reported the feasibility of 










flocked swab or 






This study reported that more than one 
specimen needed to detect SARS-CoV-2. 
Iwasaki 
2020 (15) 










collected by the 
patients and spit 





This result estimate that the viral load in 
saliva was equivalent at earlier time, but 
lower than nasopharyngeal samples. 
Kojima 
2020 (16) 























Supervised self-collected oral fluid and 
anterior nasal swab specimens 
performed similarly to clinician-collected 
nasopharyngeal swab specimens for the 
detection of SARS-CoV-2. No sample type 
captured all infections. 
Landry 
2020 (17) 
USA 124 - - 









Saliva had an overall sensitivity for SARS 
CoV-2 RNA detection of 85.7 % when 


















Posterior oropharyngeal saliva is an 
acceptable alternative specimen to 
nasopharyngeal specimen for the 
detection of SARS-CoV-2. 
 
